Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
TAG Oil prepares for flow testing of its first unconventional oil well in Egypt (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News IPI Legacy Liquidation Co IMPLQ

Healthcare Biotechnology
IPI Legacy Liquidation Co, formerly Impel Pharmaceuticals Inc., is not engaged in any business operations. The Company doesn’t hold any assets.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (PINL:IMPLQ)

Impel Pharmaceuticals Announces Filing of Voluntary Chapter 11 Cases and Signing of "Stalking Horse" Agreement to Facilitate Sale

PR Newswire December 19, 2023

Impel Pharmaceuticals Announces Exploration of Strategic Alternatives

GlobeNewswire October 5, 2023

Impel Pharmaceuticals to Present New Real-World Data for Trudhesa® at the 65th Annual Scientific Meeting of the American Headache Society

GlobeNewswire June 15, 2023

Impel Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update

GlobeNewswire May 12, 2023

Impel Pharmaceuticals Announces Appointment of Michael W. Kalb as Chief Financial Officer

GlobeNewswire May 10, 2023

Impel Pharmaceuticals to Report First Quarter 2023 Financial Results on Friday, May 12, 2023

GlobeNewswire May 5, 2023

Impel Pharmaceuticals Presents New Data at AAN 2023 Suggesting Trudhesa® Nasal Spray is Safe to Use When Co-Administered With Commonly Prescribed Migraine Medications

GlobeNewswire April 26, 2023

Impel Pharmaceuticals Announces Appointment of Darren Cline to the Board of Directors

GlobeNewswire April 12, 2023

Impel Pharmaceuticals to Present Data on Trudhesa® Nasal Spray for Treatment of Acute Migraine at 2023 American Academy of Neurology Annual Meeting

GlobeNewswire April 11, 2023
View More News ››

Opinion & Analysis (PINL:IMPLQ)

No current opinion is available.
View More Opinion ››

Bullboard Posts (PINL:IMPLQ)

IMPL - Friday Rundown, Monday Expectations

<< View Post To Watch Video >>
HDavis - September 10, 2021

IMPL - Thursday Rundown, Friday Expectations

<< View Post To Watch Video >>
HDavis - September 9, 2021

IMPL - The Run Starts

<< View Post To Watch Video >>
HDavis - September 9, 2021
View more Bullboard ››

Nexera Energy Inc

Nexera Energy Inc

Nexera Energy Inc. is a Canada-based energy company with oil producing properties in southwest Texas. The Company is engaged ...
View More »